Parminder Singh

Large language models (LLMs) for inferring genomic characteristics and facilitating genomic literacy in prostate cancer (PCa) patients.

2025 · 1 Zit. · Journal of Clinical Oncology

A framework for living evidence synthesis in cancer: Living, interactive network meta-analysis for first-line treatment of metastatic renal cell carcinoma (mRCC).

2021 · 1 Zit. · Journal of Clinical Oncology

Leveraging large language models (LLM) to guide adjuvant treatment recommendations for renal cell carcinoma (RCC) after nephrectomy.

2026 · 0 Zit. · Journal of Clinical Oncology

Development and Training of an Artificial Intelligence (AI)-Based Clinical Trial Matching Tool for Oncology.

2020 · 0 Zit. · AMIA

Artificial intelligence (AI)–assisted eligibility screening for prostate cancer clinical trial matching.

2026 · 0 Zit. · Journal of Clinical Oncology